-
Something wrong with this record ?
PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration
J. Táborská, A. Blanquer, E. Brynda, E. Filová, L. Stiborová, V. Jenčová, K. Havlíčková, Z. Riedelová, T. Riedel
Language English Country New Zealand
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2009-01-01
Taylor & Francis Open Access
from 2006-09-01
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
PubMed
36760757
DOI
10.2147/ijn.s393890
Knihovny.cz E-resources
- MeSH
- alpha-2-Antiplasmin MeSH
- Endothelial Cells MeSH
- Wound Healing MeSH
- Humans MeSH
- Nanofibers * MeSH
- Bandages MeSH
- Polyesters pharmacology MeSH
- Vascular Endothelial Growth Factor A * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: The formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ε-caprolactone) and poly(ε-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. METHODS: Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. RESULTS: The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. DISCUSSION: The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004252
- 003
- CZ-PrNML
- 005
- 20230425141234.0
- 007
- ta
- 008
- 230418s2023 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/IJN.S393890 $2 doi
- 035 __
- $a (PubMed)36760757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Táborská, Johanka $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000222357647
- 245 10
- $a PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration / $c J. Táborská, A. Blanquer, E. Brynda, E. Filová, L. Stiborová, V. Jenčová, K. Havlíčková, Z. Riedelová, T. Riedel
- 520 9_
- $a INTRODUCTION: The formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ε-caprolactone) and poly(ε-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. METHODS: Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. RESULTS: The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. DISCUSSION: The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a vaskulární endoteliální růstový faktor A $7 D042461
- 650 _2
- $a alfa-2-antiplasmin $7 D000979
- 650 _2
- $a polyestery $x farmakologie $7 D011091
- 650 _2
- $a endoteliální buňky $7 D042783
- 650 _2
- $a hojení ran $7 D014945
- 650 _2
- $a obvazy $7 D001458
- 650 12
- $a nanovlákna $7 D057139
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Blanquer, Andreu $u Department of Biomaterials and Tissue Engineering, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $u Departament de Biologia Cellular, Fisiologia i Immunologia, Universitat Autonoma de Barcelona, Bellaterra, Spain $1 https://orcid.org/0000000235511885
- 700 1_
- $a Brynda, Eduard $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Filová, Elena $u Department of Biomaterials and Tissue Engineering, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/000000016215197X $7 xx0074200
- 700 1_
- $a Stiborová, Lenka $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Jenčová, Věra $u Department of Chemistry, Technical University of Liberec, Liberec, Czech Republic $1 https://orcid.org/0000000173919526 $7 xx0069522
- 700 1_
- $a Havlíčková, Kristýna $u Department of Chemistry, Technical University of Liberec, Liberec, Czech Republic
- 700 1_
- $a Riedelová, Zuzana $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Riedel, Tomáš $u Department of Chemistry and Physics of Surfaces and Biointerfaces, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000229716956 $7 xx0232941
- 773 0_
- $w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 18, č. - (2023), s. 595-610
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36760757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141231 $b ABA008
- 999 __
- $a ok $b bmc $g 1924741 $s 1190461
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 18 $c - $d 595-610 $e 20230203 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
- LZP __
- $a Pubmed-20230418